Loading...
592 Europe Pharmaceuticals Reports
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Merck & Co. Inc., Bristol-Myers Squibb, OSE Immunotherapeutics, Amgen Inc., GlaxoSmithKline PLC
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Cardinal Health Inc., Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Merck KGaA, Integra LifeSciences Corporation, Cook Biotech Incorporated, Thermo Fisher Scientific, Smith & Nephew (Osiris Therapeutics)
Country Covered: France
Study Period: 2019 - 2029
Major Players: AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Johnson & Johnson
Country Covered: Spain
Study Period: 2019 - 2029
Major Players: Sanofi SA, GlaxoSmithKline PLC, Bayer, Pfizer Inc, Reckitt Benckiser Group PLC
Region Covered: Europe
Study Period: 2019-2029
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Danone S.A. (Nutricia), Abbott, Nestlé (Nestlé Health Science), Baxter International, B. Braun SE
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: United Kingdom, Germany, France, Russia, Spain, Italy
Major Players: Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Biocon
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Meyrs Squibb Company, F. Hoffmann-La Roche Ltd
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United Kingdom, Germany, France, Italy, Spain
Major Players: Aspen Pharmacare Holdings Limited, Piramal Group, Baxter International, AbbVie Inc., Viatris Inc.
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Johnson & Johnson, Smith & Nephew, Stryker Corporation, Medtronic PLC, CONMED Corporation
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: France, Germany, Italy, Spain, United Kingdom, Russia
Major Players: AstraZeneca, Takeda, Novartis, Merck & Co., Inc., Eli Lilly and Company
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia
Major Players: Novo Nordisk, AstraZeneca, Eli lilly and Company, Sanofi, Pfizer
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: United Kingdom, Germany, Italy, Spain, France, Russia
Major Players: Eli Lilly, Astrazeneca, Novo Nordisk, Sanofi, Boehringer Ingelheim
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: France, Germany, Italy, Spain, United Kingdom, Russia
Major Players: Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Janssen Pharmaceuticals, Eli Lilly and Company
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: France, Germany, Italy, Russia, Spain, United Kingdom
Major Players: Teva, Bristol-Myers Squibb, AstraZeneca, Sanofi Aventis, Merck and Co.
Country Covered: Iceland
Study Period: 2019 - 2029
Major Players: Alvogen, Johnson & Johnson, Novartis AG, Pfizer Inc, Sanofi SA
Country Covered: Denmark
Study Period: 2019 - 2029
Major Players: Novo Nordisk A/S, Leo Pharma A/S, H. Lundbeck A/S, Orifarm Group A/S, ALK-Abelló Nordic A / S
Country Covered: Netherlands
Study Period: 2019 - 2029
Major Players: Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Novartis AG, F. Hoffmann-La Roche AG
Country Covered: Norway
Study Period: 2019 - 2029
Major Players: AbbVie Inc., Bayer AG, Boehringer Ingelheim, GSK plc, AstraZeneca
Country Covered: Finland
Study Period: 2019 - 2029
Major Players: AbbVie Inc., AstraZeneca plc, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, GlaxoSmithKline plc
Country Covered: Italy
Study Period: 2019 - 2029
Major Players: AbbVie Inc., AstraZeneca plc, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, GlaxoSmithKline plc
Country Covered: Sweden
Study Period: 2019 - 2029
Major Players: Amgen Inc., Pfizer Inc., Novartis International AG, Orifarm Group A/S, Merck & Co., Inc.
Country Covered: Belgium
Study Period: 2019 - 2029
Major Players: C.H. Boehringer Sohn AG & Ko. KG, AstraZeneca plc, AbbVie Inc., Bayer AG, GlaxoSmithKline plc
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United Kingdom, Germany, France, Italy, Spain, Russia
Major Players: Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca, Biocon
Country Covered: United Kingdom
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Country Covered: France
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Sanofi Aventis, Novo Nordisk A/S, Eli Lilly and Company
Country Covered: Spain
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, Novo Nordisk
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Germany
Study Period: 2019-2029
Major Players: Bayer AG, Sanofi SA, Johnson & Johnson, Reckitt Benckiser Group PLC, Haleon Group of Companies
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia
Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon
Filter Reports
By Countries
